Last updated at 02 Jul 2024 02:14 PM
Director
DIN: 02202070
Havahumma Abdulaziz is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at DONN BUILDERS AND DEVELOPERS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02202070.Havahumma Abdulaziz is currently involved in 2 different roles. Their most recent position is with MEDISUITE LIFE SCIENCE PRIVATE LIMITED as a Director. The first company Havahumma Abdulaziz was appointed to as a director was DONN BUILDERS AND DEVELOPERS PRIVATE LIMITED. Havahumma Abdulaziz is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Havahumma Abdulaziz is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at DONN BUILDERS AND DEVELOPERS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02202070.Havahumma Abdulaziz is currently involved in 2 different roles. Their most recent position is with MEDISUITE LIFE SCIENCE PRIVATE LIMITED as a Director. The first company Havahumma Abdulaziz was appointed to as a director was DONN BUILDERS AND DEVELOPERS PRIVATE LIMITED. Havahumma Abdulaziz is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
3y 5m 1y 9m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
DONN BUILDERS AND DEVELOPERS PRIVATE LIMITED | Director | 01-Sep-2008 |
MEDISUITE LIFE SCIENCE PRIVATE LIMITED | Director | 05-Aug-2022 |
MEDISUITE LIFE SCIENCE PRIVATE LIMITED | Individual Promoter | 05-Aug-2022 |